Search

Du, Yiqin, Nirmala SundarRaj, Martha L Funderburgh, Stephen A Harvey, David E Birk, and James L Funderburgh. 2007. “Secretion and Organization of a Cornea-Like Tissue in Vitro by Stem Cells from Human Corneal Stroma.”. Investigative Ophthalmology & Visual Science 48 (11): 5038-45.

Karamichos, Dimitrios, Martha L Funderburgh, Audrey E K Hutcheon, James D Zieske, Yiqin Du, Jian Wu, and James L Funderburgh. 2014. “A Role for Topographic Cues in the Organization of Collagenous Matrix by Corneal Fibroblasts and Stem Cells.”. PloS One 9 (1): e86260.

Yam, Gary Hin-Fai, Shaohua Pi, Yiqin Du, and Jodhbir S Mehta. 2023. “Posterior Corneoscleral Limbus: Architecture, Stem Cells, and Clinical Implications.”. Progress in Retinal and Eye Research 96: 101192.

Kaur, Satinder, Peri Sohnen, Sudha Swamynathan, Yiqin Du, Edgar M Espana, and Shivalingappa K Swamynathan. 2023. “Molecular Nature of Ocular Surface Barrier Function, Diseases That Affect It, and Its Relevance for Ocular Drug Delivery.”. The Ocular Surface 30: 3-13.

Shojaati, Golnar, Irona Khandaker, Kyle Sylakowski, Martha L Funderburgh, Yiqin Du, and James L Funderburgh. 2018. “Compressed Collagen Enhances Stem Cell Therapy for Corneal Scarring.”. Stem Cells Translational Medicine 7 (6): 487-94.

Du, Yiqin, Danny S Roh, Martha L Funderburgh, Mary M Mann, Kacey G Marra, Peter Rubin, Xuan Li, and James L Funderburgh. 2010. “Adipose-Derived Stem Cells Differentiate to Keratocytes in Vitro.”. Molecular Vision 16: 2680-9.

Du, Yiqin, Martha L Funderburgh, Mary M Mann, Nirmala SundarRaj, and James L Funderburgh. 2005. “Multipotent Stem Cells in Human Corneal Stroma.”. Stem Cells (Dayton, Ohio) 23 (9): 1266-75.

Chan, Audrey A, Andrew J Hertsenberg, Martha L Funderburgh, Mary M Mann, Yiqin Du, Katherine A Davoli, Jocelyn Danielle Mich-Basso, Lei Yang, and James L Funderburgh. 2013. “Differentiation of Human Embryonic Stem Cells into Cells With Corneal Keratocyte Phenotype.”. PloS One 8 (2): e56831.

Nguyen, NgocUyenNhi. 2025. “An FDA-Approved Drug Structurally and Phenotypically Corrects the K210del Mutation in Genetic Cardiomyopathy Models”. Journal of Clinical Investigation 32 (7): 1789-1804.

“Comprehensive Analysis of Bulk and Single-Cell RNA Sequencing Data Reveals Schlafen-5 (SLFN5) As a Novel Prognosis and Immunity”. 2024. International Journal of Medical Sciences 21: 2348-64.